Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDIO | Common Stock | Options Exercise | $12.5K | +8.8K | +14.02% | $1.42 | 71.6K | Mar 31, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDIO | Restricted Stock Units | Options Exercise | -$12.5K | $37.5K | Mar 31, 2024 | Common Stock | $12.5K | $0.00 | Direct | F2, F3, F4 |
Id | Content |
---|---|
F1 | Represents the settlement of restricted stock units (RSUs) that vested on December 31, 2023 through the issuance of shares of Common Stock. |
F2 | Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I. |
F3 | On January 23, 2024, the reporting person was awarded $50,000 in value of RSUs, $12,500 in value of which vested on March 31, 2024. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on June 30, 2024, $12,500 in value on September30, 2024 and $12,500 in value on December 31, 2024, based on the closing price of the Issuers common stock on the applicable vesting date. |
F4 | The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. |